Man Ho Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Man Ho Choi has a total of 272 co-authors. Here are the top co-authors by number of shared publications:
- Bong Chul Chung
Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul 02792, Korea
20 shared publications Ju-Yeon Moon
Korea Institute of Science and Technology
16 shared publications- Jung Hee Kim
Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
9 shared publications Dong Jun Byun
Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul, Republic of Korea
7 shared publicationsHyun-Hwa Son
Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea
6 shared publicationsChaelin Lee
Center for Advanced Molecular Recognition, Korea Institute of Science and Technology , Seoul 02792
5 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
Salivary 18-Hydroxycortisol as a Noninvasive Marker for Lateralization in Primary Aldosteronism
- 6 October 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
Open AccessSalivary 18-Hydroxycortisol as a Noninvasive Marker for Lateralization in Primary Aldosteronism
- Open Access
- 1 October 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (11) , 4468-4493
Intratumoral androstene-3,17-dione defines breast cancer subtype and prognosis
Androgens inhibit breast cancer (BC) growth in estrogen receptor (ER)-positive BC and promote growth in ER-negative BC. Correlating intratumoral androgens, instead of circulating androgens, and their downstream transcriptome, a measure of free unbound androgen function, may offer a direct assessment of androgen action in BC. Intratumoral androgen androstenedione (A4) levels in BC specimens correlated with 1388 genes, which classified patients into low, intermediate, and high A4 levels. This A4-high patients’ transcriptome was associated with lower tumor cell proliferation, earlier stage and grade, and longer survival, while A4-low patients’ transcriptome was associated with the triple-negative subtype. We developed a 90-gene A4-associated transcriptional classifier that captures intratumoral A4-associated biology. The signature requires independent validation. snRNAseq analysis indicated that high A4 specimens were enriched for favorable cell lineage, while low A4 specimens were enriched for aggressive cell lineage and cancer hallmarks. Supporting in vitro evidence suggests that A4 can inhibit ER-positive AR-positive BC cells. Collectively, these data show that intratumoral A4 levels are associated with a transcriptional state linked to lower proliferation, more luminal features, and better BC outcome.
- 1 October 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (11) , 4468-4493
Open AccessIntratumoral androstene-3,17-dione defines breast cancer subtype and prognosis
Androgens inhibit breast cancer (BC) growth in estrogen receptor (ER)-positive BC and promote growth in ER-negative BC. Correlating intratumoral androgens, instead of circulating androgens, and their downstream transcriptome, a measure of free unbound androgen function, may offer a direct assessment of androgen action in BC. Intratumoral androgen androstenedione (A4) levels in BC specimens correlated with 1388 genes, which classified patients into low, intermediate, and high A4 levels. This A4-high patients’ transcriptome was associated with lower tumor cell proliferation, earlier stage and grade, and longer survival, while A4-low patients’ transcriptome was associated with the triple-negative subtype. We developed a 90-gene A4-associated transcriptional classifier that captures intratumoral A4-associated biology. The signature requires independent validation. snRNAseq analysis indicated that high A4 specimens were enriched for favorable cell lineage, while low A4 specimens were enriched for aggressive cell lineage and cancer hallmarks. Supporting in vitro evidence suggests that A4 can inhibit ER-positive AR-positive BC cells. Collectively, these data show that intratumoral A4 levels are associated with a transcriptional state linked to lower proliferation, more luminal features, and better BC outcome.
- Open Access
- 14 August 2026
- Published by Wiley in Journal of Internal Medicine
- Vol. 300 (4) , 513-527
Liver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity
Background: Liver cirrhosis (LC) is frequently complicated by adrenal dysfunction; however, whether cirrhosis drives the coordinated, pathway‐specific reprogramming of cortisol metabolism remains unclear. Objectives: We aimed to characterize axis‐specific alterations in cortisol metabolism in patients with LC, those with adrenal insufficiency (AI), and controls using integrated serum and salivary steroid profiling. Methods: This prospective study included adults with LC ( n = 33) and control participants without cirrhosis who underwent cosyntropin‐stimulation test following transsphenoidal surgery for a nonfunctioning pituitary adenoma (controls, n = 27; AI, n = 10). Serum and saliva samples were collected at baseline, 30 and 60 min after stimulation and profiled for 26 serum and 12 salivary steroids through liquid chromatography–tandem mass spectrometry. Multivariate models were constructed to identify cirrhosis‐associated steroid features, and their associations with disease severity. Results: LC was characterized by axis‐specific steroid remodeling, including suppressed 11β‐hydroxysteroid dehydrogenase 1 and A‐ring reduction activity with the 20α‐reduction pathway activation. Representative changes included a lower peak cortisol‐to‐cortisone ratio and reduced tetrahydrocortisone‐to‐cortisone ratio, alongside increased 20α‐reduced metabolites (all p < 0.001). This pattern was distinct from that in AI, in which steroid production and downstream metabolites were uniformly reduced. Iterative model refinement identified a parsimonious seven‐steroid signature that discriminated patients with LC from controls. Within the LC cohort, the steroid signature correlated with the Child–Pugh score. Conclusion: LC is associated with coordinated, axis‐specific cortisol metabolic reprogramming, which is mechanistically distinct from AI. Integrated steroid profiling may provide mechanistic insight into altered glucocorticoid metabolism in cirrhosis and its relationship to disease severity .
- 14 August 2026
- Published by Wiley in Journal of Internal Medicine
- Vol. 300 (4) , 513-527
Open AccessLiver cirrhosis is associated with altered glucocorticoid metabolism related to disease severity
Background: Liver cirrhosis (LC) is frequently complicated by adrenal dysfunction; however, whether cirrhosis drives the coordinated, pathway‐specific reprogramming of cortisol metabolism remains unclear. Objectives: We aimed to characterize axis‐specific alterations in cortisol metabolism in patients with LC, those with adrenal insufficiency (AI), and controls using integrated serum and salivary steroid profiling. Methods: This prospective study included adults with LC ( n = 33) and control participants without cirrhosis who underwent cosyntropin‐stimulation test following transsphenoidal surgery for a nonfunctioning pituitary adenoma (controls, n = 27; AI, n = 10). Serum and saliva samples were collected at baseline, 30 and 60 min after stimulation and profiled for 26 serum and 12 salivary steroids through liquid chromatography–tandem mass spectrometry. Multivariate models were constructed to identify cirrhosis‐associated steroid features, and their associations with disease severity. Results: LC was characterized by axis‐specific steroid remodeling, including suppressed 11β‐hydroxysteroid dehydrogenase 1 and A‐ring reduction activity with the 20α‐reduction pathway activation. Representative changes included a lower peak cortisol‐to‐cortisone ratio and reduced tetrahydrocortisone‐to‐cortisone ratio, alongside increased 20α‐reduced metabolites (all p < 0.001). This pattern was distinct from that in AI, in which steroid production and downstream metabolites were uniformly reduced. Iterative model refinement identified a parsimonious seven‐steroid signature that discriminated patients with LC from controls. Within the LC cohort, the steroid signature correlated with the Child–Pugh score. Conclusion: LC is associated with coordinated, axis‐specific cortisol metabolic reprogramming, which is mechanistically distinct from AI. Integrated steroid profiling may provide mechanistic insight into altered glucocorticoid metabolism in cirrhosis and its relationship to disease severity .
- 5 September 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , e827-e836
Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal Diseases
Context: Although salivary steroid sampling offers several advantages, the diagnostic potential of salivary steroid metabolites remains largely unexplored. Objective: This work aimed to evaluate the diagnostic utility of salivary steroid profiling in patients with adrenal diseases. Methods: This prospective, multicenter study comprised 313 patients with nonfunctioning adrenal adenoma (NF), primary aldosteronism (PA), Cushing syndrome (CS), and mild autonomous cortisol secretion (MACS). Salivary samples for morning and night steroids were collected using standardized protocols. The liquid chromatography–mass spectrometry–based steroid profiling was applied to quantify cortisol, cortisone, tetrahydrocortisone (THE), 20α-dihydrocortisol (20α-DHF), 18-hydroxycortisol (18-OHF), and dehydroepiandrosterone sulfate (DHEA-S). The primary outcome was the diagnostic performance of morning and night salivary steroids Results: In the PA group, morning and night salivary levels of 18-OHF were higher compared to the other groups (all P < .05). Morning and night salivary levels of cortisone, THE, and 20α-DHF were significantly elevated in the CS group compared to other groups (all P < .05). Only night-time salivary levels of cortisone (P = .040) and 20α-DHF (P = .029) were elevated in the MACS group compared to the NF group. Receiver operating characteristic analyses indicated that morning salivary 18-OHF was moderately specific for PA, whereas night salivary 20α-DHF and cortisone provided robust diagnostic accuracy for CS. Combined night salivary steroids exhibited superior diagnostic performance compared to morning salivary steroids in the CS group (area under the curve, 0.903 vs 0.754; P = .007). Conclusion: Salivary steroid profiling holds promise as a noninvasive tool for the diagnosis of adrenal diseases.
- 5 September 2025
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (3) , e827-e836
Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal Diseases
Context: Although salivary steroid sampling offers several advantages, the diagnostic potential of salivary steroid metabolites remains largely unexplored. Objective: This work aimed to evaluate the diagnostic utility of salivary steroid profiling in patients with adrenal diseases. Methods: This prospective, multicenter study comprised 313 patients with nonfunctioning adrenal adenoma (NF), primary aldosteronism (PA), Cushing syndrome (CS), and mild autonomous cortisol secretion (MACS). Salivary samples for morning and night steroids were collected using standardized protocols. The liquid chromatography–mass spectrometry–based steroid profiling was applied to quantify cortisol, cortisone, tetrahydrocortisone (THE), 20α-dihydrocortisol (20α-DHF), 18-hydroxycortisol (18-OHF), and dehydroepiandrosterone sulfate (DHEA-S). The primary outcome was the diagnostic performance of morning and night salivary steroids Results: In the PA group, morning and night salivary levels of 18-OHF were higher compared to the other groups (all P < .05). Morning and night salivary levels of cortisone, THE, and 20α-DHF were significantly elevated in the CS group compared to other groups (all P < .05). Only night-time salivary levels of cortisone (P = .040) and 20α-DHF (P = .029) were elevated in the MACS group compared to the NF group. Receiver operating characteristic analyses indicated that morning salivary 18-OHF was moderately specific for PA, whereas night salivary 20α-DHF and cortisone provided robust diagnostic accuracy for CS. Combined night salivary steroids exhibited superior diagnostic performance compared to morning salivary steroids in the CS group (area under the curve, 0.903 vs 0.754; P = .007). Conclusion: Salivary steroid profiling holds promise as a noninvasive tool for the diagnosis of adrenal diseases.
- 6 April 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (10) , 1073-1081
Intravenous Dexamethasone Transiently Elevates Blood Glucose Levels and Reduces Pain After TKA in Patients with Type-2 Diabetes Mellitus
Background: Effective perioperative blood glucose control is crucial for reducing postoperative complications in patients with diabetes mellitus (DM) who are undergoing total knee arthroplasty (TKA). The aim of this study was to assess the impact of intravenous (IV) dexamethasone on blood glucose levels, insulin requirements, postoperative pain, and postoperative nausea and vomiting (PONV) in patients with well-controlled type-2 DM. Methods: A total of 83 Asian patients with well-controlled type-2 DM (defined as a preoperative glycated hemoglobin level of ≤7.0%) undergoing primary TKA were randomized to receive either IV dexamethasone or normal saline solution. Blood glucose and insulin requirements were monitored postoperatively up to day 5, and pain and PONV were assessed using a numeric rating scale. Results: Compared with the control, IV dexamethasone transiently elevated blood glucose levels on the day of surgery and on postoperative day 1, with the levels returning to baseline by day 3. Insulin requirements were higher in the intervention group on postoperative day 1 (p = 0.004). While IV dexamethasone did not significantly reduce PONV, it effectively alleviated postoperative pain up to day 3. Conclusions: In patients with DM who underwent TKA, IV dexamethasone administration transiently increased blood glucose on the day of surgery and on postoperative day 1 and elevated insulin requirements on postoperative day 1. Despite having no impact on PONV, IV dexamethasone provided clinical benefits by reducing early postoperative pain. These findings suggest the potential benefits of IV dexamethasone in enhancing perioperative management strategies for patients with DM who are undergoing TKA. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
- 6 April 2025
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (10) , 1073-1081
Intravenous Dexamethasone Transiently Elevates Blood Glucose Levels and Reduces Pain After TKA in Patients with Type-2 Diabetes Mellitus
Background: Effective perioperative blood glucose control is crucial for reducing postoperative complications in patients with diabetes mellitus (DM) who are undergoing total knee arthroplasty (TKA). The aim of this study was to assess the impact of intravenous (IV) dexamethasone on blood glucose levels, insulin requirements, postoperative pain, and postoperative nausea and vomiting (PONV) in patients with well-controlled type-2 DM. Methods: A total of 83 Asian patients with well-controlled type-2 DM (defined as a preoperative glycated hemoglobin level of ≤7.0%) undergoing primary TKA were randomized to receive either IV dexamethasone or normal saline solution. Blood glucose and insulin requirements were monitored postoperatively up to day 5, and pain and PONV were assessed using a numeric rating scale. Results: Compared with the control, IV dexamethasone transiently elevated blood glucose levels on the day of surgery and on postoperative day 1, with the levels returning to baseline by day 3. Insulin requirements were higher in the intervention group on postoperative day 1 (p = 0.004). While IV dexamethasone did not significantly reduce PONV, it effectively alleviated postoperative pain up to day 3. Conclusions: In patients with DM who underwent TKA, IV dexamethasone administration transiently increased blood glucose on the day of surgery and on postoperative day 1 and elevated insulin requirements on postoperative day 1. Despite having no impact on PONV, IV dexamethasone provided clinical benefits by reducing early postoperative pain. These findings suggest the potential benefits of IV dexamethasone in enhancing perioperative management strategies for patients with DM who are undergoing TKA. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 17 September 2024
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 28 (1) , 466-480
Gender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection
Hepatitis B virus (HBV) is a sex-specific pathogen that is more severe in males than in females. Sex disparities in HBV infection have been attributed to hormonal differences between males and females. However, whether HBV infection affects the metabolic signatures of steroid hormones and how these influences viral replication remains unclear. In this study, we investigated whether HBV infection alters steroid metabolism and its effects on HBV replication. Serum samples from male and female mice obtained after the hydrodynamic injection of replication-competent HBV plasmids were subjected to quantitative steroid profiling. Serum steroid levels in mice were analyzed using an in vitro metabolism assay with the mouse liver S9 fraction. The alteration of steroids by HBV infection was observed only in male mice, particularly with significant changes in androgens, whereas no significant hormonal changes were observed in female mice. Among the altered steroids, dehydroepiandrosterone (DHEA) levels increased the most in male mice after HBV infection. An in vitro metabolism assay revealed that androgen levels were significantly reduced in HBV-infected male mice. Furthermore, the genes involved in DHEA biosynthesis were significantly upregulated in HBV-infected male mice. Interestingly, reduced dihydrotestosterone in male mice significantly inhibits viral replication by suppressing HBV promoter activity, suggesting a viral strategy to overcome the antiviral effects of steroid hormones in males. Our data demonstrated that HBV infection can cause sex-specific changes in steroid metabolism.
- 17 September 2024
- Published by Taylor & Francis in Animal Cells and Systems
- Vol. 28 (1) , 466-480
Open AccessGender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection
Hepatitis B virus (HBV) is a sex-specific pathogen that is more severe in males than in females. Sex disparities in HBV infection have been attributed to hormonal differences between males and females. However, whether HBV infection affects the metabolic signatures of steroid hormones and how these influences viral replication remains unclear. In this study, we investigated whether HBV infection alters steroid metabolism and its effects on HBV replication. Serum samples from male and female mice obtained after the hydrodynamic injection of replication-competent HBV plasmids were subjected to quantitative steroid profiling. Serum steroid levels in mice were analyzed using an in vitro metabolism assay with the mouse liver S9 fraction. The alteration of steroids by HBV infection was observed only in male mice, particularly with significant changes in androgens, whereas no significant hormonal changes were observed in female mice. Among the altered steroids, dehydroepiandrosterone (DHEA) levels increased the most in male mice after HBV infection. An in vitro metabolism assay revealed that androgen levels were significantly reduced in HBV-infected male mice. Furthermore, the genes involved in DHEA biosynthesis were significantly upregulated in HBV-infected male mice. Interestingly, reduced dihydrotestosterone in male mice significantly inhibits viral replication by suppressing HBV promoter activity, suggesting a viral strategy to overcome the antiviral effects of steroid hormones in males. Our data demonstrated that HBV infection can cause sex-specific changes in steroid metabolism.
- Open Access
- 23 July 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 562, 119886
Dried blood spot-based free sterol signatures in sitosterolemia diagnostics
- 23 July 2024
- Published by Elsevier in Clinica Chimica Acta
- Vol. 562, 119886
Open AccessDried blood spot-based free sterol signatures in sitosterolemia diagnostics
- Open Access
- 24 June 2024
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 78 (8) , 473-481
Cholesterol profiling reveals 7β‐hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer's disease
Aim: Cholesterol homeostasis is associated with Alzheimer's disease (AD). Despite the multitude of cholesterol metabolites, little is known about which metabolites are directly involved in AD pathogenesis and can serve as its potential biomarkers.Methods: To identify “hit” metabolites, steroid profiling was conducted in mice with different age, diet, and genotype and also in humans with normal cognition, mild cognitive impairment, and AD using gas chromatography–mass spectrometry. Then, using one of the “hit” molecules (7β‐hydroxycholesterol; OHC), molecular and histopathological experiment and behavioral testing were conducted in normal mice following its intracranial stereotaxic injection to see whether this molecule drives AD pathogenesis and causes cognitive impairment.Results: The serum levels of several metabolites, including 7β‐OHC, were increased by aging in the 3xTg‐AD unlike normal mice. Consistently, the levels of 7β‐OHC were increased in the hairs of patients with AD and were correlated with clinical severity. We found that 7β‐OHC directly affects AD‐related pathophysiology; intrahippocampal injection of 7β‐OHC induced astrocyte and microglial cell activation, increased the levels of pro‐inflammatory cytokines (TNF‐alpha, IL‐1β, IL‐6), and enhanced amyloidogenic pathway. Mice treated with 7β‐OHC also exhibited deficits in memory and frontal/executive functions assessed by object recognition and 5‐choice serial reaction time task, respectively.Conclusions: Our results suggest that 7β‐OHC could serve as a convenient, peripheral biomarker of AD. As directly involved in AD pathogenesis, 7β‐OHC assay may help actualize personalized medicine in a way to identify an at‐risk subgroup as a candidate population for statin‐based AD treatment.
- 24 June 2024
- Published by Wiley in Psychiatry and Clinical Neurosciences
- Vol. 78 (8) , 473-481
Open AccessCholesterol profiling reveals 7β‐hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer's disease
Aim: Cholesterol homeostasis is associated with Alzheimer's disease (AD). Despite the multitude of cholesterol metabolites, little is known about which metabolites are directly involved in AD pathogenesis and can serve as its potential biomarkers.Methods: To identify “hit” metabolites, steroid profiling was conducted in mice with different age, diet, and genotype and also in humans with normal cognition, mild cognitive impairment, and AD using gas chromatography–mass spectrometry. Then, using one of the “hit” molecules (7β‐hydroxycholesterol; OHC), molecular and histopathological experiment and behavioral testing were conducted in normal mice following its intracranial stereotaxic injection to see whether this molecule drives AD pathogenesis and causes cognitive impairment.Results: The serum levels of several metabolites, including 7β‐OHC, were increased by aging in the 3xTg‐AD unlike normal mice. Consistently, the levels of 7β‐OHC were increased in the hairs of patients with AD and were correlated with clinical severity. We found that 7β‐OHC directly affects AD‐related pathophysiology; intrahippocampal injection of 7β‐OHC induced astrocyte and microglial cell activation, increased the levels of pro‐inflammatory cytokines (TNF‐alpha, IL‐1β, IL‐6), and enhanced amyloidogenic pathway. Mice treated with 7β‐OHC also exhibited deficits in memory and frontal/executive functions assessed by object recognition and 5‐choice serial reaction time task, respectively.Conclusions: Our results suggest that 7β‐OHC could serve as a convenient, peripheral biomarker of AD. As directly involved in AD pathogenesis, 7β‐OHC assay may help actualize personalized medicine in a way to identify an at‐risk subgroup as a candidate population for statin‐based AD treatment.
- Open Access
- 1 December 2023
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 8 (1) , bvad155
Multiplexed Serum Steroid Profiling Reveals Metabolic Signatures of Subtypes in Congenital Adrenal Hyperplasia
Context Altered metabolic signatures on steroidogenesis may characterize individual subtypes of congenital adrenal hyperplasia (CAH), but conventional diagnostic approaches are limited to differentiate subtypes. Objective We explored metabolic characterizations and identified multiple diagnostic biomarkers specific to individual subtypes of CAH. Methods Liquid chromatography-mass spectrometry-based profiling of 33 adrenal steroids was developed and applied to serum samples obtained from 67 CAH patients and 38 healthy volunteers. Results Within- and between-run precisions were 95.4% to 108.3% and 94.1% to 110.0%, respectively, while all accuracies were 0.910. Metabolic ratios corresponding to 21-hydroxylase characterized 21-hydroxylase deficiency (21-OHD; n = 63) from healthy controls (area under the curve = 1.0, P < 1 × 10−18 for all) and other patients with CAH in addition to significantly increased serum 17α-hydroxyprogesterone (P < 1 × 10−16) and 21-deoxycortisol (P < 1 × 10−15) levels. Higher levels of mineralocorticoids, such as corticosterone (B) and 18-hydroxyB, were observed in 17α-hydroxylase deficiency (17α-OHD; N = 3), while metabolic ratio of dehydroepiandrosterone sulfate to pregnenolone sulfate was remarkably decreased against all subjects. A patient with 11β-hydroxylase deficiency (11β-OHD) demonstrated significantly elevated 11-deoxycortisol and its metabolite tetrahydroxy-11-deoxyF, with reduced metabolic ratios of 11β-hydroxytestosterone/testosterone and 11β-hydroxyandrostenedione/androstenedione. The steroid profiles resulted in significantly decreased cortisol metabolism in both 21-OHD and 17α-OHD but not in 11β-OHD. Conclusion The metabolic signatures with specific steroids and their corresponding metabolic ratios may reveal individual CAH subtypes. Further investigations with more substantial sample sizes should be explored to enhance the clinical validity.
- 1 December 2023
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 8 (1) , bvad155
Open AccessMultiplexed Serum Steroid Profiling Reveals Metabolic Signatures of Subtypes in Congenital Adrenal Hyperplasia
Context Altered metabolic signatures on steroidogenesis may characterize individual subtypes of congenital adrenal hyperplasia (CAH), but conventional diagnostic approaches are limited to differentiate subtypes. Objective We explored metabolic characterizations and identified multiple diagnostic biomarkers specific to individual subtypes of CAH. Methods Liquid chromatography-mass spectrometry-based profiling of 33 adrenal steroids was developed and applied to serum samples obtained from 67 CAH patients and 38 healthy volunteers. Results Within- and between-run precisions were 95.4% to 108.3% and 94.1% to 110.0%, respectively, while all accuracies were 0.910. Metabolic ratios corresponding to 21-hydroxylase characterized 21-hydroxylase deficiency (21-OHD; n = 63) from healthy controls (area under the curve = 1.0, P < 1 × 10−18 for all) and other patients with CAH in addition to significantly increased serum 17α-hydroxyprogesterone (P < 1 × 10−16) and 21-deoxycortisol (P < 1 × 10−15) levels. Higher levels of mineralocorticoids, such as corticosterone (B) and 18-hydroxyB, were observed in 17α-hydroxylase deficiency (17α-OHD; N = 3), while metabolic ratio of dehydroepiandrosterone sulfate to pregnenolone sulfate was remarkably decreased against all subjects. A patient with 11β-hydroxylase deficiency (11β-OHD) demonstrated significantly elevated 11-deoxycortisol and its metabolite tetrahydroxy-11-deoxyF, with reduced metabolic ratios of 11β-hydroxytestosterone/testosterone and 11β-hydroxyandrostenedione/androstenedione. The steroid profiles resulted in significantly decreased cortisol metabolism in both 21-OHD and 17α-OHD but not in 11β-OHD. Conclusion The metabolic signatures with specific steroids and their corresponding metabolic ratios may reveal individual CAH subtypes. Further investigations with more substantial sample sizes should be explored to enhance the clinical validity.
- Open Access
- 6 October 2023
- Published by Elsevier in Journal of Lipid Research
- Vol. 64 (11) , 100453
LC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines
- 6 October 2023
- Published by Elsevier in Journal of Lipid Research
- Vol. 64 (11) , 100453
Open AccessLC-MS based simultaneous profiling of adrenal hormones of steroids, catecholamines, and metanephrines